S01LA04 ranibizumab
ATC group of level 5 – chemical substance · in plain English: eye medicines
This site has the patient leaflet or the SPC of 12 medicines in this group.
- 7 prescription only (POM)
Active substance: Ranibizumab – all medicines with this substance, also in combinations.
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- S Sensory organ drugs 367 medicines
- S01 Ophthalmologicals 349 medicines
- S01L Ocular vascular disorder agents 30 medicines
- S01LA Antineovascularisation agents 30 medicines
- S01LA04 ranibizumab 12 medicines
- S01LA Antineovascularisation agents 30 medicines
- S01L Ocular vascular disorder agents 30 medicines
- S01 Ophthalmologicals 349 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Byooviz 10 mg / ml solution for injection SPC | Prescription only (POM) |
| Byooviz 10 mg/ml solution for injection in Pre-filled syringe SPC | Prescription only (POM) |
| Fovlussea 10 mg/ml solution for injection SPC | – |
| Fovlussea 10 mg/ml solution for injection in Pre-filled syringe SPC | – |
| Lucentis 10 mg / ml solution for injection SPC | – |
| Lucentis 10 mg / ml solution for injection in Pre-filled syringe SPC | Prescription only (POM) |
| Ongavia 10 mg/ml solution for injection SPC | Prescription only (POM) |
| Ongavia 10 mg/ml solution for injection in Pre-filled syringe SPC | Prescription only (POM) |
| Ranluspec 10 mg/ml solution for injection SPC | – |
| Ranluspec 10 mg/ml solution for injection in Pre-filled syringe SPC | – |
| Rimmyrah 10 mg/ml solution for injection in Pre-filled syringe | Prescription only (POM) |
| Ximluci 10 mg/ml solution for injection SPC | Prescription only (POM) |
Other groups of the same level
- S01LA01 verteporfin 1 medicine
- S01LA03 pegaptanib 1 medicine
- S01LA05 aflibercept 14 medicines
- S01LA06 brolucizumab 2 medicines
Other names of the ATC group
- Czech: S01LA04 Ranibizumab
- French: S01LA04 ranibizumab
- German: S01LA04 Ranibizumab
- Spanish: S01LA04 Ranibizumab
- German: S01LA04 Ranibizumab
- Italian: S01LA04 Ranibizumab
- Polish: S01LA04 Ranibizumab
- Turkish: S01LA04 ranibizumab
- Portuguese (Brazil): S01LA04 Ranibizumab
- German (Switzerland): S01LA04 Ranibizumab
- French (Switzerland): S01LA04 Ranibizumab
- Italian (Switzerland): S01LA04 Ranibizumab
- English (Canada): S01LA04 Ranibizumab
- French (Canada): S01LA04 Ranibizumab
- Slovak: S01LA04 Ranibizumab
- Dutch: S01LA04 Ranibizumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group S01LA04
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.